EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer: Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations

Potenzial von Phytochemikalien zur Hemmung von Nuclear receptor binding SET domain protein 2 bei Krebs: Pharmakophor-Screening, molekulares Docking, ADME-Analysen und molekulardynamische Simulationen

Gamal A Mohamed, Hossam M Abdallah iD, Ikhlas A Sindi, Sabrin R M Ibrahim iD, Abdulrahim A Alzain

PLOS ONE · 20.08.2024 · 19 (8) · e0308913

DOI: 10.1371/journal.pone.0308913 ↗

Auf einen Blick

In-silico-Studie zu natürlichen Verbindungen als potenziellen NSD2-Inhibitoren bei Krebs. Zehn Kandidaten übertrafen den Referenzinhibitor im Docking; drei Hits zeigten stabile Protein-Ligand-Komplexe.

Fragestellung

Können natürliche Verbindungen NSD2 als Zielstruktur für Krebsmedikamente potenziell hemmen?

Methode

In-silico-Ansatz mit Pharmakophor-Modellierung, Docking, pharmakokinetischem Profiling und molekulardynamischen Simulationen.

Ergebnisse

49.248 natürliche Verbindungen aus SuperNatural 3.0 wurden gescreent. Zehn Kandidaten übertrafen den Referenzinhibitor im G-Score; die Top-3-Hits zeigten Interaktionen mit dem NSD2-PWWP1-Domänentarget und stabile Komplexe über 200 ns.

Schlussfolgerung der Autor:innen

Die Autoren identifizierten vielversprechende natürliche Verbindungen als potenzielle pharmazeutische Wirkstoffe für NSD2-assoziierte Krebserkrankungen.

Kernaussagen

  • 49.248 Naturstoffe wurden per e-Pharmacophore-Screening ausgewählt.
  • 10 Kandidaten übertrafen den Referenzinhibitor im Docking.
  • Die Top-3-Hits zeigten stabile Komplexe in 200-ns-Simulationen.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 20.08.2024. Verfasst von Gamal A Mohamed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Molecular Docking Simulation, Molecular Dynamics Simulation, Pharmacophore. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear receptor binding SET domain protein 2 (NSD2) significantly contributes to the development of cancer, making it a promising target for cancer drug discovery. This research explores natural compounds as potential selective inhibitors for NSD2 in cancer treatment. Employing a comprehensive in silico approach, the study utilized pharmacophore modeling, molecular docking, pharmacokinetic profiling, and molecular dynamics simulations. An e-pharmacophore model-based screening using the first selective and potent ligand bound to NSD2 identified 49,248 natural compounds from the SuperNatural 3.0 database (containing 449,008 molecules) with acceptable alignment with the developed pharmacophore hypotheses. Subsequently, molecular docking was executed to assess the standout compounds which led to the selection of ten candidates that surpassed the reference inhibitor in accordance w the binding affinity expressed as a G score. Ligand-residue interaction analyses of the top three hits (SN0450102, SN0410255, and SN0142336) revealed diverse crucial interactions with the NSD2 active site, including hydrogen bonds, pi-pi stacking, and hydrophobic contacts with key amino acid residues in the NSD2-PWWP1 domain. Pharmacokinetic profiling confirmed the drug-likability for the refined hits, indicating good cellular permeability and minimal blood-brain barrier penetration. Molecular dynamics simulations for 200 nanoseconds affirmed the stability of protein-ligand complexes, with minimal fluctuations in root mean square deviation and root mean square fluctuation analyses. Overall, this study identified promising natural compounds as potential pharmaceutical agents in the treatment of NSD2-associated cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone-Lysine N-MethyltransferaseMolecular Docking SimulationMolecular Dynamics SimulationPharmacophorePhytochemicalsRepressor ProteinsHumansDrug DiscoveryHydrogen BondingLigandsNeoplasmsProtein Binding

Substanzen

Histone-Lysine N-MethyltransferaseLigandsNSD2 protein, humanPhytochemicalsRepressor Proteins

Autor:innen und Institutionen

  • Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Biology, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Chemistry, Preparatory Year Program, Batterjee Medical College, Jeddah, Saudi Arabia.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Wad Madani, Sudan.

ORCID-Profile: Hossam M Abdallah, Sabrin R M Ibrahim

Zitieren

APA

Mohamed, G. A., Abdallah, H. M., Sindi, I. A., Ibrahim, S. R. M., & Alzain, A. A. (2024). Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer: Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations. PLOS ONE, 19(8), e0308913. https://doi.org/10.1371/journal.pone.0308913

Vancouver

Mohamed GA, Abdallah HM, Sindi IA, Ibrahim SRM, Alzain AA. Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer: Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations. PLOS ONE. 2024;19(8):e0308913. doi:10.1371/journal.pone.0308913

BibTeX
@article{Mohamed2024,
  author = {Mohamed, Gamal A and Abdallah, Hossam M and Sindi, Ikhlas A and Ibrahim, Sabrin R M and Alzain, Abdulrahim A},
  title = {Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer: Pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {8},
  pages = {e0308913},
  doi = {10.1371/journal.pone.0308913}
}
Kostenlos starten →